News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s
Whether you are just starting your first vial or transitioning between dose levels, every number you need is right here
You Are Undersleeping or Overstressed Lifestyle factors, such as sleep and stress, play a much greater role in weight loss than you may think
Medical liver biopsy: background, indications, procedure and histopathology
Side Effects While both medications can cause some stomach upset, like nausea or diarrhea, how people react can vary
People on GLP-1s "can become more sensitive to alcohol, and sugary cocktails can make them feel nauseated," George told me